Head-to-head comparison
SkinnyRx vs TeleCareSpot
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Both molecules by needle or by tablet, with the whole term ladder printed on the product page before any intake — and a headline rate that is the twelve-month rung, charged as one $2,388 payment on day one.
$349/mo sema · $399/mo tirz · Verified August 2026
Marked down on: FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026; the letter is public in FDA's warning-letter database
FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.
Desk Score
TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat.
$299/mo (+ membership fee) sema · $399/mo tirz · Verified June 2026
Marked down on: The LegitScript seal ID this provider publishes, #45936855, does not resolve on LegitScript's own CDN — checked August 2026, alongside six seal IDs from other providers that returned normally in the same pass
SkinnyRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 71/100 (C) for TeleCareSpot. TeleCareSpot still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
SkinnyRx
78/100
C+
TeleCareSpot
71/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | SkinnyRx | TeleCareSpot |
|---|---|---|
| Semaglutide | $349/mo$349/mo month-to-month (compounded; the advertised rate is a 12-month prepay) | $299/mo+ membership fee$299/mo (all doses, plus a separate fee, compounded) |
| Tirzepatide | $399/mo$399/mo month-to-month (compounded; the advertised rate is a 12-month prepay) | $399/mo$399/mo |
| Coverage | 47 states + DC (not Alabama, Louisiana or Mississippi) | 48 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | People who want a tablet route on either molecule and can pay a year up front; anyone shopping month to month should compare $349 and $399, not the advertised $199 and $299. | Flat-priced compounded semaglutide or tirzepatide with broad state coverage. |
| Desk Score | 78/100C+ | 71/100C |
The verdict
Desk pick — SkinnyRxSkinnyRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 71/100 (C) for TeleCareSpot. TeleCareSpot still holds its ground where its strengths line up with yours.
Choose SkinnyRx if…
People who want a tablet route on either molecule and can pay a year up front; anyone shopping month to month should compare $349 and $399, not the advertised $199 and $299.
$349/mo sema · $399/mo tirz · 47 states + DC (not Alabama, Louisiana or Mississippi)
FDAWarning letter issued to Lean Rx, Inc. dba SkinnyRx in February 2026. See the FDA warning-letter database.
Choose TeleCareSpot if…
Flat-priced compounded semaglutide or tirzepatide with broad state coverage.
$299/mo (+ membership fee) sema · $399/mo tirz · 48 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: SkinnyRx · TeleCareSpot.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs SkinnyRx
- CoreAge Rx vs TeleCareSpot
- Apex MD vs SkinnyRx
- Apex MD vs TeleCareSpot
- NovoCare Pharmacy vs SkinnyRx
- Kova vs TeleCareSpot
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.